Since IL-6 accounts significantly for obesity-related basal lipolysis in adipose tissue (2), we went on to test whether Phillyrin treatment could lower plasma level of glycerol, a product of lipolysis, in HFD-fed mice. The gene discussed is IL6; the disease is obesity disorder.